Nicole Leonard

The open enrollment period for health insurance coverage in 2023 through the Affordable Care Act begins Nov. 1 and ends in January.

National Prescription Drug Take Back Day was launched a decade ago to address rising rates of addiction and overdoses linked to prescription opioids.

Despite an overall decline in cases, higher lead exposures continue to be concentrated in neighborhoods such as Strawberry Mansion, Brewerytown, Germantown, and Cobbs Creek.

Fentanyl continues to drive overdose deaths in Philadelphia and Pennsylvania. But cases involving xylazine, para-fluorofentanyl, and gabapentin grow.

The Philadelphia-based poison control center recorded a slight uptick in mushroom poisoning cases, including at least one that caused organ failure.

The U.S. surgeon general chose Philadelphia as the site to launch a national guide for how employers can improve workplace mental health and wellness.

A year after suffering from a gunshot wound to the head outside his North Philadelphia school, Ivan Cuevas and his family show what survivorship can look like.

Emergency kits will be installed at schools by the end of October. Each kit contains several doses of naloxone, the opioid overdose reversal medication.

Union groups at Temple University Hospital have been in contract negotiations since August. They’re prepared to strike if an agreement isn’t reached.

Researchers at the Children’s Hospital of Philadelphia studied how exposure therapy can help kids overcome excessive anxiety related to their food allergies.

A number of circulating viruses are causing rising rates of respiratory infections in kids, with hospitals and ICUs seeing an uptick in admissions.

Two biotech companies announced last week that preliminary trial data show their new Alzheimer’s drug, lecanemab, slowed cognitive decline.